The 2001 WHO Classification included cytogenetics in MDS classification, and the updated 2016 WHO classification first includes the status of SF3B1 mutation in the classification of MDS with ring sideroblasts15,16. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.